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SUMMARY
Introduction: The high polymorphism of the HLA system allows its typification to be used as valuable tool in establishing
association to various illnesses, immune and genetic profiles; it also provides a guide to identifying compatibility among
donors and receptors of organs transplants.
Objective: To establish HLA-A, HLA-B, and HLA.DRB1 allele, genotype and haplotype frequencies among patients
treated at Clinica Colsanitas SA.
Methods: 561 patients coming from different regions in Colombia, who were attended in 8 centers of the clinical
laboratory of the Clinica Colsanitas in different cities of the country from January 2004 to August 2008, were included in this
study. All were HLA-A,-B, and -DRB1 typified via SSP PCR. Allele, genotype and haplotype frequencies were estimated
with STATA Software Version 9.0 and the GENEPOP genetic analysis package.
Results: 19, 28, and 15 different alleles were identified for loci HLA-A,-B and -DRB1, respectively. Alleles found most
frequently were A*24 (26.2%), A*02 (26%), B*35(22.7%), and DRB1*04 (24%). The most frequent genotypes were
A*02,24 (14.2%), B*07,35 (5.5%), DRB1*01,04, and DRB1*04,04 (6.9%); while most the frequent haplotypes were HLA
A*24, B*35 (9.2%), A*24, DRB1*04 (8.1%); B*35, DRB1*04 (7.8%), A*2 DRB1*04 (7.4%).
Conclusion: The results obtained provide a useful reference framework for the population studied, allowing compatibility
probability calculations to be performed for organ transplants.
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RESUMEN
Introducción: El alto polimorfismo del sistema HLA, hace que su tipificación sea una herramienta de gran valor al
establecer asociación con diferentes enfermedades, patrones inmunológicos, antropogenéticos, así como para establecer
probabilidades de encontrar donantes compatibles con receptores de diferentes tipos de trasplante de órganos.
Objetivo: Establecer las frecuencias alélicas, genotípicas y haplotípicas en pacientes atendidos en la Clínica Colsanitas
SA.
Metodología: Se incluyeron un total de 561 pacientes atendidos en el Laboratorio Clínico de La Clínica Colsanitas SA,
en 8 sedes en diferentes ciudades del Colombia, durante el período comprendido entre enero de 2004 a agosto de 2008. Se
realizó tipificación de HLA -A,-B,-DRB1 por PCR SSP. Las frecuencias alélicas, genotípicas y haplotípicas fueron estimadas
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mediante el paquete estadístico Stata y el paquete de análisis
genético Genepop.
Resultados: Fue posible la identificación de 19, 28 y 15
alelos de los loci HLA A-B-DRB1 respectivamente, de los
cuales los más frecuentes fueron A*24 (26.2%), A*02 (26%),
B*35 (22.7%), DRB1*04 (24%). Los genotipos más fre-
cuentes encontrados fueron A*02,24 (14.2%), B*07,35
(5.5%), DRB1*01,04 y DRB1*04,04 (6.9%). Los haplotipos
más frecuentes fueron: HLA A*24, B*35 (9.2%), A*24,
DRB1*04 (8.1%); B* 35, DRB1*04 (7.8%), A*2 DRB1*04
(7.4%).
Conclusión: Los resultados obtenidos permiten tener
referencia para aplicaciones en la población estudiada, así
como para establecer probabilidades de compatibilidad en la
creciente área de trasplante de órganos.
 Colomb Med. 2010; 41: 336-43
Palabras clave: HLA; Genotipos; Haplotipos;
Genes; Alelos.
The human leukocyte antigen system (HLA) of the
major histocompatibility complex (MHC) contains a
numerous family of genes located on the short arm of
the 6th chromosome (6p21.1-6p21.3). These antigens
are expressed in autosomal and codominant manner
and they are inherited from both parents, which is why
each individual expresses an antigen of paternal origin
and one of maternal origin for each of the loci1.
The high polymorphism of the HLA system and
advancements in molecular biology have permitted for
the typifying of these antigens to become important
tools in establishing associations of susceptibility or
resistance to disease, development of tumor processes;
playing an important role in understanding the variability
of the immune response and determinant on the survival
of organ or tissue transplants2-8.
Because the allele frequencies and the disequilibrium
patterns vary within a given population, the
characterization of these molecules and the determi-
nation of their frequencies gain much pertinence and
permits establishing parameters of association to disease
in the population, which has a predictive value in
managing self-immune diseases like Systemic
Erythematosus Lupus (SEL) and Rheumatoid Arthritis
(RA), also becoming an important tool for the
distribution of organs donated in the different transplant
groups in the National Donation Network, as well as
having an additional usefulness in estimating times the
receptors must remain in the waiting list9,10.
Most of the Latin American populations studied are
of indigenous origin or barely mixed11-15. The population
treated in the Molecular Biology laboratory at Clinica
Colsanitas SA for HLA typifying comes from different
Colombian cities, offering an opportunity to determine
the allele, genotype, and haplotype frequencies in
patients of diverse origins.
MATERIALS AND METHODS
Design and population. This is a retrospective
descriptive study, which included 561 patients treated
in the cities of Bogota, Cali, Barranquilla, Medellin,
Villavicencio, Armenia, Bucaramanga, and Neiva. The
patients underwent HLA A,-B and -DRB1 typifying in
the Molecular Biology laboratory at Clinica Colsanitas
between January 2004 and August 2008.
Definition of variables. The variables of interest for
this study were: demographic characteristics (gender,
age, place of birth), alleles for each of the 3 loci
analyzed (HLA A*, HLA B*, HLA DRB1*), as well as
the genotypes and haplotypes found.
Procedure of HLA typifying. DNA extraction was
carried out with the Wizard® Genomic DNA Purification
kit, adhering to the protocol recommended by the
manufacturer from the white blood cell layer obtained
from blood samples anticoagulated with EDTA or from
spleen fragments contained in sterile containers,
hermetically sealed in an RPMI medium supplemented
with fetal calf serum.
The final concentration for each of the samples was
adjusted at 120 ng/µl and then the HLA-A, HLA-B, and
HLA-DRB1 genes were determined via single specific
primer polymerase chain reaction (SSP PCR) as per
manufacturer instructions (Biotest ABDR SSPtray).
Thereafter, electrophoresis was conducted on the
amplification products in agarose gels at 2% dyed with
SYBR® Safe DNA gel (Invitrogen). An analysis was
performed of amplified bands by using Quantity One
(BIORAD), leaving a photo record and the allele
assignation was made by employing the tables provided,
as well as the Biotest SSP typing software.
Statistical analysis. Proportions were calculated to
summarize the qualitative variables. The normality of
the age variable was evaluated by using the Shapiro-
Wilk test and summarized with a mean.
Homologation of the degree of resolution of the
typifying to two digits was done on the data base for
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Table 1
Population distribution per department
 Note the greatest representation for Cundinamarca, 44.2%; followed
by Boyacá (11.3%), Santander (7.9%), Huila (7.2%), Atlántico
(4.9%), and Cesar (2.7%).
Table 2
HLA A Allele frequencies*
further analysis of allele, genotype, and haplotype
frequencies16.
The p values lower than or equal to 0.05 were
considered significant. The allele, genotype, and
haplotype frequencies and those corresponding to
demographic characteristics were calculated in the
Stata 9.0/SE program. The Linkage disequilibrium
between loci pairs, the Fisher fixation index, and the
Hardy Weinberg equilibrium were estimated by






























employing the GENEPOP genotype analysis package
version 1.217, which bears in mind the modifications to
the Markov chain algorithm described by Guo and
Thompson17.
Ethical considerations. This study used data from
patients whose samples had already been taken and
processed; hence, there was no additional risk. The
confidentiality of the information was strictly protected.
The samples had been taken after obtaining signed
informed consent from the patients or their families and
through medical request.
RESULTS
Demographic characteristics. Of the total number
of patients included in the study, we obtained information
on the place of birth from 443 patients; who came from
28 departments in Colombia, with a greater represen-
tation from Cundinamarca, followed by Boyaca,
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distribution per department can be seen in Table 1.
Of the individuals included, 57.4% were male and
42.6% female, the mean age was 38 years of age with a
range from 1 to 85 years. Within the population analyzed,
there were patients who attended outpatient consultation
to have the sample taken, as well as patients who were
under pre-transplant study by the group at Clinica
Colsanitas SA and cadaveric donors from the 1st regio-
nal facilities of the transplant network typified by the
renal transplant group at Clinica Reina Sofia.
Allele frequencies. It was possible to determine 19,
28, and 15 alleles of the HLA A-B-DRB1 loci,
respectively, in the population studied. The most
frequent alleles in the HLA-A locus were A*24 (26.2%),
A*02 (26%), A*01 (7.6%), A*68 (6.5%), and A*29
(6.4%); followed by A*03, A*39, A*33, A*11, A31,
A*23, A*26, and A*32 with frequencies over 1%
(Table 2).
The most frequent alleles in the HLA- B locus were
B*35(22.7%), B*44 (11.1%), B*07 (8.6%), B*51(8%);
followed by B*40, B*14, B*39, B*15, B*18, B*38,
B*13, B*48, B*27, B49, B*58, B*57, and B*45 with
frequencies over 1% (Table 3). The most frequent
alleles in the HLA-DRB1 locus were DRB1*04 (24.1%),
DRB1*15 (11.3%), DRB1*07 (11.1%), DRB1*01
(10.3%), and DRB1*13 (8.3%); followed by DRB1*11,
DRB1*08, DRB1*14, DRB1*16, and DRB1*17 with
frequencies over 3% (Table 4).
Genotype frequencies. We observed 90 different
genotypes for the HLA-A locus, 144 genotypes for
HLA-B, and 99 for HLA-DRB1; the most frequent
genotypes for the HLA-A locus were: A*02,24 (14.2%),
A*24,24 (7.3%), A*02,02(6.1%), A*02,68 (4.3%), and
A*01,02 (3.95%). Graphic 1 shows the genotypes for
each of the loci analyzed, which reveal frequencies
over 1%.
The genotypes revealing the highest frequencies for
the HLA B locus were: B*07,35 (5.53%), B*35,44
(4.63%), B*35,35 (4.28%), and B*14,35 (3.21%); for
the HLA DRB1 locus, the most observed genotypes
were: DRB1*01,04 and DRB1*04,04 (6.95%); followed
by DRB1*04,15 (4.3%), DRB1*04,13(4.1%),
DRB1*04,11 (3.6%), and DRB1*04,07 (3.6%).
The Hardy-Weinberg equilibrium for each locus
was tested through the GENEPOP program, obtaining
a deficiency of heterozygous individuals for DRB1
genotypes with p: 0.0091 and reaching a Fisher fixation
Table 3
HLA B Allele frequencies*
* Estimated via the Stata 9.0/SE program
index of + 0.0344; while the genotype frequencies for
the HLA A and HLA B loci were within the Hardy-
Weinberg equilibrium (Table 5).
The linkage disequilibrium values among the
haplotypes analyzed were significant, obtaining p=
0.00992 between the HLA A and HLA B loci, p=
0.0012 for the HLA A and HLA DR loci, and p= 0.026
for the HLA B and HLA DR loci.
Haplotype frequencies. The most commonly found
HLA A, B haplotypes in the population studied were:
HLA A*24 B*35 (9.2%); followed by A*02 B35 (5.2%),
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 Graphic 1. HLA-A, HLA-B, and HLA-DRB1 genotype frequencies over 1%
A*02 B*51 (3.1%), A*24 B*40 (2.9%), A*02 B*44
(2.68%). The most frequent HLA B, DR haplotypes
were: HLA B*35 DRB1*04 (7.8%), B*44 DRB1*07
(3.38%), B*07, and DRB1*15 (2.6%), and for HLA A,
Table 4
HLA DRB1 Allele frequencies*
















* Estimated via the Stata 9,0/SE program




































































































































DR: A*24 DRB1*04 (8.1%), A*2 DRB1*04 (7.4%),
and A*02 DRB1*15 (3.2%). The haplotypes showing
frequencies over 1% are described in Graphic 2.
DISCUSSION
It was possible to determine the level of the A locus
for 19 alleles, similar to those reported by Ossa et al.14,
for a population from the city of Bogotá. When
comparing with a study reported in cadaveric donors
conducted in the city of Medellín, it was determined
that the A43 and A80 alleles were not identified, and
which were observed in this study. The frequencies
obtained were similar for the first two places of the A*
locus as those reported by Ossa et al.14, and Rodriguez
et al.9, for a Colombian population; however, differences
in alleles were found, like: A*01, A*68, A*29, which
show higher frequencies (7.6%, 6.5%, 6.4%) with
respect to that reported in the Medellin, Colombia study
(5.1%, 5.6%, 3.7%).
The analyses made by Ossa et al.14, reveal similar
frequencies for the HLA A locus to those reported in the
current study. The differences observed in relation to
the Medellín study may arise because even though it is
a Colombian population, they present information from
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a specific city; while in our case, the individuals come
from different parts of the nation, which makes it a
heterogeneous population.
The results obtained in this study correlate to those
previously reported for a Latin American population,
where the alleles with the greatest frequency were A02,
A24, A01, and A6814,15,18.
Only 28 alleles were identified for the B locus; while
in prior studies conducted in Colombian populations,
43 alleles were reported for this locus9,14. This marked
difference is attributable to the resolution of the
technique used in typifying HLA in our study, given
that is some instances such resolution did not permit
differentiation of the B15, B14, and B40 splits in the
allelic variants currently considered. Of the total
population typified as B14 (6.2%), 3.2% were
differentiated as B64, B65, and B14, where B65 corres-
ponded to the greatest frequency, but since it was not
possible to define such in a broad percentage, they were
reported for the current study as B14.
The HLA B*15 corresponded to 3.3% of the
population. For this allele, we were not able to identify
in all typifying events the specificity B62, B63, B70,
B71, B72, and B75, because of the resolution of the kit
used in typifying. Thus, the B15 frequency we found is
higher than that reported in previous studies in Colom-
Table 5
Hardy-Weinberg test. H1= Heterozygote deficiency
   Locus                           Homozygotes                          Homozygotes                    Fis           p
                                      expected  observed           expected  observed
HLA-A 89.5727 91 471.4272 470 +0-0030 0.1193
HLA-B 53.9126 49 507.0874 512 -0.0097 0.7759
HLA-DRB1 66.0027 83 494.9974 478 +0.0344 0.0091
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bia. As well as for the B14 and B15 alleles, for the B40
allele we were not able to differentiate between the B61
and B60 alleles; hence, the frequency found for B40 is
a reflection of the 3 alleles (B40, B60, and B61). It is
important to stress that the B*46, B*47, B*67, and
B*78 alleles whose frequency is equal to or lower than
0.2 %, were not found in the population analyzed in this
study, contrasting with that reported by Rodriguez et
al.9, which is possible bearing in mind that the size of
our sample is smaller than that analyzed in the city of
Medellín.
The most common alleles for the HLA B, B*35, and
B*44 loci basically correspond to that reported in prior
studies in a Colombian population9 and correlate with
the frequencies mostly observed in populations of Uru-
guay, Peru, and Argentina11,12,15; nevertheless, there are
some differences with that reported by Ossa et al.14 in
population from the city of Bogotá, which may be due
to the heterogeneity of the population in the current
study.
At the DRB1* locus level, we found 15 alleles, with
the most common being: DRB1*04, DRB1*15,
DRB1*07, DRB1*01, DRB1*13, DRB1*11, DRB1*08,
DRB1*14, DRB1*16, and DRB1*17, which are also
the ones found with the greatest frequency in prior
studies in Colombian and Latin populations, although
Rodriguez et al.9,  found a higher frequency (13.4%) for
the DRB1*13 allele and a lower frequency (10%) for
the DRB1*15 allele in relation to those obtained in this
study (8.3%) and (11.3%), respectively. When
comparing our results to the study with the population
in the city of Bogota published by Ossa et al.14,  there
are small differences regarding the order of the alleles
found.
Upon reviewing the information on haplotypes found
in the population studied, we have that the most frequent
HLA A, B haplotypes were A*24 B*35, A*2 B*35,
A*2 B*51, and A*29 B*44, which correlates with the
reports found in studies conducted on Latin popu-
lations19; and haplotypes A*02 B*44 and A*02 B*07
with important frequencies in this study are reported
most frequently in Caucasian populations. Regarding
HLA B DRB1 haplotypes, the first two places were
occupied by HLA B*35 DRB1*04 and B*44 DRB1*07,
correlating with that reported by Rodríguez et al.9 and
they are the haplotypes found in greater frequency in a
Hispanic population19,20.
It is worth mentioning that since B40 is an important
component of high-frequency haplotypes, it is necessary
to employ techniques that permit differentiating the
B60, B61, and B40 allelic variants, which this study
could not establish; hence, the haplotypes in which the
B40 is included may be actually made up of any of the
corresponding variants and, thus, in prior studies A*24
B*61 occupy a greater frequency, which would be
included in the A*24 B*40 haplotype reported in our
study because of the resolution of the technique used.
The results of the current study correspond mostly to
that previously reported for Colombia, where we found
a typical component of Latin population with an
important Caucasian influence; nevertheless, the
differences evidence the variations in the size and
origin of the population studied, as well as the important
influence of the resolution of the technique used in
typifying.
Given the heterogeneity of the population analyzed
in the current study, it is important to keep the following
aspects in mind: these were mostly patients attending
outpatient consultation for whom typifying was
requested for pre-transplant study in different cities of
the nation, they belonged to groups of patients studied
to be included in the waiting list for renal transplant or
suspect of clinical association to a specific disease, and
in a minor proportion they were cadaveric donors from
the 1st regional facilities of the National Transplant
Network.
All these factors may undoubtedly be associated to
the results obtained in this study; however, it should be
noted that of patients in renal pre-transplant study only
10% are related to self-immune diseases and, generally,
HLA-disease association studies estimate that the
differential association of different alleles in different
populations is merely a reflection of the different
distribution of frequencies of the HLA haplotypes or
alleles in said populations. For this reason, more than
having healthy individuals or patients in the population
the origin does set an important relevant factor with
respect to the distribution of frequencies.
Conducting this study permitted us to know the
genotype, allele, and haplotype frequencies of the
population analyzed and offers us useful tools to
establish probabilities of finding compatible donors for
patients in waiting lists for renal transplant. Furthermore,
it establishes the need for conducting high-resolution
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typifying and, thus, obtaining more precise data and
promoting greater compatibility in the area of trans-
plants.
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